{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
NRX Pharmaceuticals, Inc.
Is NRX Pharmaceuticals, Inc. technically bullish or bearish?
As of June 5, 2025, the technical trend is bullish with moderate strength, supported by bullish MACD, moving averages, and Bollinger Bands, although the weekly RSI indicates some short-term weakness.
What does NRX Pharmaceuticals, Inc. do?
NRX Pharmaceuticals, Inc. is a blank check company in the Pharmaceuticals & Biotechnology sector focused on business combinations. It has a market cap of $57.75 million and reported a net profit loss of $6 million as of March 2025.
How big is NRX Pharmaceuticals, Inc.?
As of Jun 18, NRX Pharmaceuticals, Inc. has a market capitalization of 57.75 million, with net sales of 0.00 million and a net profit of -24.11 million over the last four quarters. The company reported shareholder's funds of -23.22 million and total assets of 3.65 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
